Article
Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Feb 1997
Chang A E, Aruga A, Cameron M J, Sondak V K, Normolle D P, Fox B A, Shu S
Abstract excerpt
PURPOSE: In preclinical studies, we have reported the ability to induce immune T cells in lymph nodes (LN) primed by in vivo vaccination with tumor cells admixed with a bacterial adjuvant. These LN cells can be activated and expanded ex vivo for the successful immunotherapy of established tumors....
Topics
- Adult
- BCG Vaccine
- CD3 Complex
- Carcinoma, Renal Cell
- Drug Screening Assays, Antitumor
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor
- Humans
- Hypersensitivity, Delayed
- Immunity, Cellular
- Immunotherapy, Adoptive
- Interferon-gamma
- Interleukin-2
